Viyash Life Sciences PVT LTD

Viyash, true to its name, literally represents honesty and leadership in every sense. We are an integrated pharmaceutical company with a strong portfolio of niche formulations, APIs and advanced intermediates Viyash and its subsidiaries operate 10 API / Intermediate facilities with a combined capacity ~2000 KL and diversified capabilities in every aspect - small / large volume, potent / non-potent, regulated / semi-regulated markets. We are an integrated pharmaceutical enterprise which is driven and agile, adaptive and committed and above all we are quality focused and customer obsessed. Commissioned API R&D facility to initiate Viyash's API development program across multiple therapeutic categories. Acquired Symed Labs, leading manufacturer of niche APIs. In addition, we also operate one formulation manufacturing facility in New Jersey, USA with a capacity of ~ 1.2 Bn units. Leading from the front and staying honest about our origin mission, the two qualities associated with the Vedic interpretation of “Viyash”, are the propellers of success for any pharmaceutical initiative.We work professionally every day with a single-minded intent to build trust and honest relationships with our community and with our customers. Our manufacturing facilities is where we make our magic and deliver on the Viyash promise of quality, agility and adaptability.